CV Sciences, Inc. launched PlusCBD Pet, a full line of hemp extracts formulated exclusively for dogs and cats.
CV Sciences, Inc. (San Diego, CA) launched PlusCBD Pet, a full line of hemp extracts formulated exclusively for dogs and cats. It is available in 250 mg and 500 mg formats in beef, chicken, peanut butter, and salmon flavors, as well as unflavored.
“PlusCBD Pet provides us with an exciting opportunity to leverage our brand equity and retail distribution channels to participate in the growing pet CBD market,” said Joseph Dowling, CEO of CV Sciences, in a press release. “We believe the pet CBD category will continue to grow as more research demonstrates the health benefits of CBD for dogs and cats. Our employees have supplemented their pets with our human PlusCBD products for years, now we are pleased to have an opportunity to help all pet parents love their pets with our soothing PlusCBD Pet products formulated specifically for animals.”
PlusCBD Pet will be sold across the company’s natural and online retail channels, with plans to expand into the pet specialty channel, as well as the food, drug, and mass retail channel.